We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

By LabMedica International staff writers
Posted on 08 Sep 2025

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine. More...

This region, the body’s largest mucosal surface, is crucial for host-microbiome interactions, metabolism, and immunity, but remains difficult to access. Researchers have now developed a swallowable capsule that passively collects microbes from the upper digestive tract, offering a clearer view of hidden bacterial communities missed by conventional stool tests.

The device, called the CORAL (Cellularly Organized Repeating Lattice) capsule, was developed by researchers from NYU Tandon School of Engineering (Brooklyn, NY, USA) in collaboration with NYU Abu Dhabi (Abu Dhabi, UAE). Inspired by the porous structures of marine corals, it is fabricated in a single 3D printing step and contains no moving parts, electronics, or magnets. Its design is based on mathematically defined Triply Periodic Minimal Surfaces (TPMS), forming a maze-like lattice that traps bacteria while allowing safe passage through the digestive tract.

A special coating ensures the capsule only begins sampling once it reaches the small intestine, preventing contamination from stomach acid. In animal studies, the capsule successfully captured distinct microbial populations that differed significantly from fecal samples. The findings, published in Device, showed higher levels of beneficial bacteria such as Lactobacillus, demonstrating that the capsule can reveal microbial communities missed by conventional methods.

The capsule’s simplicity and scalability make it a promising tool for microbiome research and clinical diagnostics. Unlike existing devices, it provides a non-invasive, passive method to map microbial ecosystems in situ. Researchers plan to scale the capsule to pill size, develop reliable retrieval methods, and conduct safety testing ahead of human trials.

"We designed CORAL to be as simple as possible, no batteries or electronics, just a mathematically precise structure that uses the gut's natural movement to sample bacteria," said Hanan Mohammed, lead author of the study. "It gives us access to bacterial communities that have been invisible to researchers until now."

Related Links:
NYU Tandon School of Engineering
NYU Abu Dhabi


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gastrointestinal Panel
Xpert® GI Panel
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.